| Financial Year |
March 31 2023 |
| Monetary Funds |
1,035,610,064.49 |
| Held-for-trading Financial Assets |
1,395,721,680.56 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,938,660,386.86 |
| Advances to Suppliers |
293,608,735.47 |
| Other Receivables |
6,281,901.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,822,132,114.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
198,335,973.39 |
| Total Current Assets |
8,459,996,568.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,497,013.35 |
| Investment Properties |
23,241,114.44 |
| Fixed Assetes |
4,823,914,115.49 |
| Under-construction Projects |
1,508,753,516.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
7,691,470.29 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
717,661,074.74 |
| R&D expenses |
110,943,208.54 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,019,632.14 |
| Deferred Income Tax Assets |
256,616,649.99 |
| Other Non-Current Assets |
469,644,373.46 |
| Sub-Total of Non-Current Assets |
9,786,704,237.57 |
| Total Assets |
18,246,700,806.38 |
| Short-Term Loans |
700,415,750.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
629,950,971.25 |
| Accounts Payable |
2,158,493,095.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
307,439,569.81 |
| Taxes Payable |
291,297,161.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
87,687,531.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
155,069,019.08 |
| Other Current Liabilities |
37,664,397.47 |
| Sub-Total of Current Liabilities |
5,562,441,806.13 |
| Long-term Loans |
200,135,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,177,724.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
552,206,226.04 |
| Total Liabilities |
6,114,648,032.17 |
| Paid-In Capital(Or Share Stock) |
1,670,705,376.00 |
| Capital Surplus |
2,342,780,896.14 |
| Surplus Reserve |
936,770,495.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,191,692,773.62 |
| Minority Stockholder's Interest |
-3,023,114.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,135,075,888.38 |
| Owner's Equity（Stockholder's Equity） |
12,132,052,774.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,246,700,806.38 |
